Novartis Investigative Site

Ventspils, LVA LV-3601

0 studies enrolling now · 2 studies all time

What they study most

Moderate to Severe Plaque-type Psoriasis, Psoriasis

Studies at this site

• Study of Secukinumab With 2 mL Pre-filled Syringes — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed